NMR Studies of Second Generation Polynuclear Platinum Compounds. Cancer affects one in four Australians and 50% of cancer patients are treated with cisplatin. BBR3464 is a new type of platinum anticancer drug that has shown promise in clinical trials, including results in cancers that do not respond to cisplatin treatment. Second-generation analogues, now under development, may offer significant advantages. This international collaboration between Prof. Berners-Price and the inventor of these ne ....NMR Studies of Second Generation Polynuclear Platinum Compounds. Cancer affects one in four Australians and 50% of cancer patients are treated with cisplatin. BBR3464 is a new type of platinum anticancer drug that has shown promise in clinical trials, including results in cancers that do not respond to cisplatin treatment. Second-generation analogues, now under development, may offer significant advantages. This international collaboration between Prof. Berners-Price and the inventor of these new drugs puts Australian research at the forefront of the clinical development. There is the potential for the generation of new IP from new strategies in the design of improved anticancer drugs. The project builds strong international links and provides international training for Australian PhD students.Read moreRead less
DNA interactions of polynuclear platinum. Mechanistic NMR studies probing the origin of the unique antitumour activity of BBR3464. BBR3464 is one of a class of structurally unique platinum anticancer drugs that is currently undergoing clinical trials. The anticancer activity most likely depends on binding to DNA, but the mechanism is quite different from that of the widely used drug, cisplatin. This project uses NMR spectroscopy to follow the processes involved in the initial binding of the dr ....DNA interactions of polynuclear platinum. Mechanistic NMR studies probing the origin of the unique antitumour activity of BBR3464. BBR3464 is one of a class of structurally unique platinum anticancer drugs that is currently undergoing clinical trials. The anticancer activity most likely depends on binding to DNA, but the mechanism is quite different from that of the widely used drug, cisplatin. This project uses NMR spectroscopy to follow the processes involved in the initial binding of the drug to DNA and the subsequent reactions of the adducts formed. The results of this work will aid in the selection of back-up clinical candidates and in the design of drugs that target specific sequences of DNA for use in novel gene-based therapies.Read moreRead less
Functional nano-porous metal membranes for sustainable separation in industrial processes. There are many waste streams that need to be purified which degrade conventional membranes. This project with local company AMS aims to develop nano-porous metal membranes as a sustainable alternative to conventional membrane materials. Highly porous and ultra-thin metal membrane sheets with narrowly distributed nano-scale pores will be fabricated and functionalised to purify both model and industrial wast ....Functional nano-porous metal membranes for sustainable separation in industrial processes. There are many waste streams that need to be purified which degrade conventional membranes. This project with local company AMS aims to develop nano-porous metal membranes as a sustainable alternative to conventional membrane materials. Highly porous and ultra-thin metal membrane sheets with narrowly distributed nano-scale pores will be fabricated and functionalised to purify both model and industrial wastewaters. This intends to lead to the production of stronger, more versatile and chemically stable membrane materials that will exhibit longer lifespan and performance. The most significant outcome is expected to be low cost metal alloys with pores below the current 100 nm benchmark and assess their thermo-chemical stability.Read moreRead less
Design and synthesis of novel lanthanoid complexes for the fabrication of light emitting devices. There is a huge and still growing economy centred around the design and fabrication of low-cost Light Emitting Devices (LEDs), as demonstrated by the excess of US$1.3 billion invested in this field between 2000 and 2007. Nations focused on the production of new and more efficient materials will be at the forefront of these emerging technologies. The major thrust of this proposal, the design and prep ....Design and synthesis of novel lanthanoid complexes for the fabrication of light emitting devices. There is a huge and still growing economy centred around the design and fabrication of low-cost Light Emitting Devices (LEDs), as demonstrated by the excess of US$1.3 billion invested in this field between 2000 and 2007. Nations focused on the production of new and more efficient materials will be at the forefront of these emerging technologies. The major thrust of this proposal, the design and preparation of luminescent rare earths complexes, and their use for the fabrication of LEDS, represent a good opportunity for Australia to access this growing market. Read moreRead less
Probing polynuclear platinum biomolecule interactions. Cancer affects one in four Australians and 50% of cancer patients are treated with cisplatin. BBR3464 is a new type of platinum anticancer drug that has shown promise in clinical trials, including results in cancers that do not respond to cisplatin treatment. Second-generation analogues, now under development, may offer significant advantages. This international collaboration with the inventor of these new drugs puts Australian research at t ....Probing polynuclear platinum biomolecule interactions. Cancer affects one in four Australians and 50% of cancer patients are treated with cisplatin. BBR3464 is a new type of platinum anticancer drug that has shown promise in clinical trials, including results in cancers that do not respond to cisplatin treatment. Second-generation analogues, now under development, may offer significant advantages. This international collaboration with the inventor of these new drugs puts Australian research at the forefront of the clinical development. There is the potential for the generation of new IP from new strategies in the design of improved anticancer drugs. The project builds strong international links and provides international training for Australian PhD students. Read moreRead less
Tuneable monodispersed nanoparticles and nanoparticle superstructures. Integrating spinning disc processing (SDP), which is new to Australia, with advances in magnetic properties of nanoparticles will have wide ranging applications in nanotechnology. The cutting edge research will foster collaboration with industry, and lead to new industries in memory device technology, nano-medicine, and catalysis, through exploiting commercial opportunities. Continuous flow SDP technology in industry has a s ....Tuneable monodispersed nanoparticles and nanoparticle superstructures. Integrating spinning disc processing (SDP), which is new to Australia, with advances in magnetic properties of nanoparticles will have wide ranging applications in nanotechnology. The cutting edge research will foster collaboration with industry, and lead to new industries in memory device technology, nano-medicine, and catalysis, through exploiting commercial opportunities. Continuous flow SDP technology in industry has a small footprint and low capital cost outlay. The project will provide excellent research training in a range of scientific skills and in professional development, and will involve overseas PhD exchange programs. The exciting research incorporating nano-toxicology will enhance public opinion towards nanotechnology.Read moreRead less
Gold-based mitochondria targeted chemotherapeutics: mechanistic studies probing interactions with thiol and selenol containing proteins. Cancer affects one in four Australians and prostate cancer is the most commonly diagnosed and second leading cause of male cancer deaths, for which there is currently no effective treatment. Current chemotherapeutics must overcome drug resistance and lack of selectivity between tumour and normal cells. To circumvent these problems we are investigating gold-base ....Gold-based mitochondria targeted chemotherapeutics: mechanistic studies probing interactions with thiol and selenol containing proteins. Cancer affects one in four Australians and prostate cancer is the most commonly diagnosed and second leading cause of male cancer deaths, for which there is currently no effective treatment. Current chemotherapeutics must overcome drug resistance and lack of selectivity between tumour and normal cells. To circumvent these problems we are investigating gold-based compounds, which act by a novel mechanism. The research will lead to new strategies in the design of improved anticancer drugs, an important Australian research priority that will promote and maintain good health. Other benefits arise from training PhD students with interdisciplinary skills for Australian biotechnology industries.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE100100236
Funder
Australian Research Council
Funding Amount
$180,000.00
Summary
Facilities for spectroscopy and diffraction at high pressures. The provision of infrastructure for the study of novel materials under high pressures will enhance Australia's capability in creating new materials and in creating new devices that meet needs in communication, environment and medicine applications. The new facility will enable researchers to understand the response of structures to extreme pressures and will exploit the unique capabilities of the synchrotron light.
Molecular Switching and Moore. Electronics technology is coming up against significant fabrication challenges. The international semiconductor community has identified molecular electronics and molecular switches as potential future technologies that can help to alleviate these growing integration challenges. This project will explore and develop a number of novel molecular switches to meet this coming need. The switches will be assessed and screened through spectroelectrochemical and computati ....Molecular Switching and Moore. Electronics technology is coming up against significant fabrication challenges. The international semiconductor community has identified molecular electronics and molecular switches as potential future technologies that can help to alleviate these growing integration challenges. This project will explore and develop a number of novel molecular switches to meet this coming need. The switches will be assessed and screened through spectroelectrochemical and computational studies of intramolecular electron transfer in mixed-valence model complexes, before migrating the most promising designs into metal-molecule-metal junctions for further assessment.Read moreRead less
Illuminating hidden processes in emissive lanthanoid complexes. This project aims to understand the antenna effect used to sensitise lanthanoid luminescence. Despite their use in modern high-tech applications, from optical fibre amplifiers (telecommunications) to luminescent probes and sensors (biological imaging), understanding is largely based on speculation or generalised 'rules-of-thumb', severely limiting progress in the field. This project will research these processes, using chemical synt ....Illuminating hidden processes in emissive lanthanoid complexes. This project aims to understand the antenna effect used to sensitise lanthanoid luminescence. Despite their use in modern high-tech applications, from optical fibre amplifiers (telecommunications) to luminescent probes and sensors (biological imaging), understanding is largely based on speculation or generalised 'rules-of-thumb', severely limiting progress in the field. This project will research these processes, using chemical synthesis, theory and spectroscopic techniques. This is expected to lead to new emissive lanthanoid-based compounds using 'a priori' approaches, with better performance than current gold standards and references. Intellectual property created will lead to new commercial products, and to creation of new Australian based spin-off/start-up companies.Read moreRead less